Tempus Wealth Planning LLC Has $2.40 Million Stock Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Tempus Wealth Planning LLC lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 30,694 shares of the company’s stock after selling 198 shares during the quarter. Tempus Wealth Planning LLC’s holdings in GE HealthCare Technologies were worth $2,400,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Optas LLC raised its position in GE HealthCare Technologies by 11.3% in the 4th quarter. Optas LLC now owns 2,937 shares of the company’s stock valued at $230,000 after purchasing an additional 298 shares during the last quarter. Jennison Associates LLC grew its holdings in GE HealthCare Technologies by 124.5% during the 4th quarter. Jennison Associates LLC now owns 1,709,635 shares of the company’s stock worth $133,659,000 after acquiring an additional 948,017 shares during the last quarter. Abner Herrman & Brock LLC increased its position in GE HealthCare Technologies by 0.8% in the 4th quarter. Abner Herrman & Brock LLC now owns 127,878 shares of the company’s stock valued at $9,997,000 after acquiring an additional 1,026 shares in the last quarter. Burford Brothers Inc. raised its stake in shares of GE HealthCare Technologies by 4.3% in the fourth quarter. Burford Brothers Inc. now owns 5,378 shares of the company’s stock worth $420,000 after acquiring an additional 221 shares during the last quarter. Finally, Spire Wealth Management bought a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at approximately $250,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on GEHC. Jefferies Financial Group upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company raised their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the company an “overweight” rating in a research note on Thursday, October 31st. One analyst has rated the stock with a sell rating, four have issued a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $96.00.

GE HealthCare Technologies Trading Down 0.9 %

Shares of GE HealthCare Technologies stock opened at $87.51 on Tuesday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.98 and a current ratio of 1.23. GE HealthCare Technologies Inc. has a 52-week low of $72.61 and a 52-week high of $94.55. The firm has a 50-day moving average of $82.97 and a 200-day moving average of $85.09. The stock has a market cap of $39.98 billion, a PE ratio of 24.04, a PEG ratio of 2.92 and a beta of 1.14.

GE HealthCare Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be given a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.16%. The ex-dividend date is Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. GE HealthCare Technologies’s payout ratio is currently 3.85%.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CEO Roland Rott sold 3,577 shares of the firm’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the sale, the chief executive officer now owns 24,298 shares of the company’s stock, valued at $2,101,291.04. This trade represents a 12.83 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.